SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

ABIOMED, Inc. – ‘8-K’ for 8/10/22 – ‘XML’

On:  Friday, 8/12/22, at 4:05pm ET   ·   For:  8/10/22   ·   Accession #:  950170-22-17121   ·   File #:  1-09585

Previous ‘8-K’:  ‘8-K’ on / for 8/4/22   ·   Next:  ‘8-K’ on 11/1/22 for 10/31/22   ·   Latest:  ‘8-K’ on / for 12/22/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/12/22  ABIOMED, Inc.                     8-K:5       8/10/22   10:203K                                   Donnelley … Solutions/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     85K 
 5: R1          Document and Entity Information                     HTML     46K 
 8: XML         IDEA XML File -- Filing Summary                      XML     11K 
 6: XML         XBRL Instance -- abmd-20220810_htm                   XML     15K 
 7: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 3: EX-101.LAB  XBRL Labels -- abmd-20220810_lab                     XML     40K 
 2: EX-101.PRE  XBRL Presentations -- abmd-20220810_pre              XML     33K 
 4: EX-101.SCH  XBRL Schema -- abmd-20220810                         XSD     11K 
 9: JSON        XBRL Instance as JSON Data -- MetaLinks               11±    17K 
10: ZIP         XBRL Zipped Folder -- 0000950170-22-017121-xbrl      Zip     18K 


‘XML’   —   XBRL Instance — abmd-20220810_htm


This Document is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink">
<link:schemaRef xlink:href="abmd-20220810.xsd" xlink:type="simple"/>
<context id="C_a7222267-3067-4ef5-90db-9e45b8f14676">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000815094 </identifier>
</entity>
<period>
<startDate> 2022-08-10 </startDate>
<endDate> 2022-08-10 </endDate>
</period>
</context>
<dei:EntityCentralIndexKey contextRef="C_a7222267-3067-4ef5-90db-9e45b8f14676" id="F_81d4f422-905b-4d5a-a3d4-e717991a24d8"> 0000815094 </dei:EntityCentralIndexKey>
<dei:AmendmentFlag contextRef="C_a7222267-3067-4ef5-90db-9e45b8f14676" id="F_6b566351-988c-41c6-9f23-b98ee81f9eb8"> false </dei:AmendmentFlag>
<dei:DocumentType contextRef="C_a7222267-3067-4ef5-90db-9e45b8f14676" id="F_64064fc5-52d0-44da-bd5b-1f5cf933d977"> 8-K </dei:DocumentType>
<dei:DocumentPeriodEndDate contextRef="C_a7222267-3067-4ef5-90db-9e45b8f14676" id="F_41fa35c7-a5da-4787-8990-13d0e63f63d3"> 2022-08-10 </dei:DocumentPeriodEndDate>
<dei:EntityRegistrantName contextRef="C_a7222267-3067-4ef5-90db-9e45b8f14676" id="F_7eccea65-c27c-4918-9c1d-bc7a3aaa72c5"> ABIOMED, Inc. </dei:EntityRegistrantName>
<dei:EntityIncorporationStateCountryCode contextRef="C_a7222267-3067-4ef5-90db-9e45b8f14676" id="F_6a4234cc-dc87-47af-9b91-9963e09d03a3"> DE </dei:EntityIncorporationStateCountryCode>
<dei:EntityFileNumber contextRef="C_a7222267-3067-4ef5-90db-9e45b8f14676" id="F_4ebf13b1-d84b-413f-8f74-a8a4c50bb338"> 001-09585 </dei:EntityFileNumber>
<dei:EntityTaxIdentificationNumber contextRef="C_a7222267-3067-4ef5-90db-9e45b8f14676" id="F_61254b63-1229-492f-bfd0-99bd444d99bb"> 04-2743260 </dei:EntityTaxIdentificationNumber>
<dei:EntityAddressAddressLine1 contextRef="C_a7222267-3067-4ef5-90db-9e45b8f14676" id="F_dc1d8639-864e-411f-ae01-b7e3ed471377"> 22 Cherry Hill Drive </dei:EntityAddressAddressLine1>
<dei:EntityAddressCityOrTown contextRef="C_a7222267-3067-4ef5-90db-9e45b8f14676" id="F_d5844e47-1d57-4f05-939d-bc4a8f6be404"> Danvers </dei:EntityAddressCityOrTown>
<dei:EntityAddressStateOrProvince contextRef="C_a7222267-3067-4ef5-90db-9e45b8f14676" id="F_4a37ae68-1412-4b7c-9d42-2a894defc361"> MA </dei:EntityAddressStateOrProvince>
<dei:EntityAddressPostalZipCode contextRef="C_a7222267-3067-4ef5-90db-9e45b8f14676" id="F_425c4d2f-c136-40a1-ac0c-0e49540a1091"> 01923 </dei:EntityAddressPostalZipCode>
<dei:CityAreaCode contextRef="C_a7222267-3067-4ef5-90db-9e45b8f14676" id="F_9e42bef9-2ae3-4b8b-b600-b2a001e0f032"> 978 </dei:CityAreaCode>
<dei:LocalPhoneNumber contextRef="C_a7222267-3067-4ef5-90db-9e45b8f14676" id="F_c26df90a-90f5-4ac2-ae8b-7f6c05da6cdc"> 646-1400 </dei:LocalPhoneNumber>
<dei:Security12bTitle contextRef="C_a7222267-3067-4ef5-90db-9e45b8f14676" id="F_c3ffab46-5711-4611-8b0e-74f985b49c92"> Common Stock, $0.01 par value </dei:Security12bTitle>
<dei:TradingSymbol contextRef="C_a7222267-3067-4ef5-90db-9e45b8f14676" id="F_acb9324f-a071-498a-98a1-d3e359b5d895"> ABMD </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="C_a7222267-3067-4ef5-90db-9e45b8f14676" id="F_77b0032d-538b-4168-bf8d-9ac4f58bc870"> NASDAQ </dei:SecurityExchangeName>
<dei:WrittenCommunications contextRef="C_a7222267-3067-4ef5-90db-9e45b8f14676" id="F_8129ba7f-f4b8-4c38-afe4-7891459da3ea"> false </dei:WrittenCommunications>
<dei:SolicitingMaterial contextRef="C_a7222267-3067-4ef5-90db-9e45b8f14676" id="F_51655079-ef11-448e-83a5-3de36ba86644"> false </dei:SolicitingMaterial>
<dei:PreCommencementTenderOffer contextRef="C_a7222267-3067-4ef5-90db-9e45b8f14676" id="F_d91e7803-5e18-450a-a813-9209083feaf2"> false </dei:PreCommencementTenderOffer>
<dei:PreCommencementIssuerTenderOffer contextRef="C_a7222267-3067-4ef5-90db-9e45b8f14676" id="F_0e48554e-7f91-402d-a8c5-0e733fb2fe19"> false </dei:PreCommencementIssuerTenderOffer>
<dei:EntityEmergingGrowthCompany contextRef="C_a7222267-3067-4ef5-90db-9e45b8f14676" id="F_0d8a577d-c3e6-40fd-b406-12b3c9180b45"> false </dei:EntityEmergingGrowthCompany>
</xbrl>

Top
Filing Submission 0000950170-22-017121   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 26, 4:12:27.1am ET